Patents Assigned to DexCom, Inc.
-
Publication number: 20260353304Abstract: Systems, techniques, and devices for performing variable power transmission for a battery-powered device are disclosed. In certain embodiments, the techniques include determining a proximity of the transmitter to a first display device. An output transmission power of the transmitter is determined based on the proximity. Analyte information from an analyte sensor coupled to the transmitter is transmitted to the first display device at the output transmission power.Type: ApplicationFiled: July 13, 2026Publication date: November 5, 2026Applicant: Dexcom, Inc.Inventors: Nathanael Richard PAUL, Jorge R. BARRERAS
-
Patent number: 12778422Abstract: In accordance with a method of communicating telemetry data employed by a risk-adaptive telemetry system, a medical device risk that a medical device will malfunction is assessed. A patient risk that the health of a patient using the medical device will fall below a predetermined acceptable level is also assessed. Telemetry data from the medical device is received, where type, amount and/or frequency of the telemetry data that is received is based at least in part on the assessed medical device risk and the patient risk.Type: GrantFiled: February 7, 2024Date of Patent: November 3, 2026Assignee: Dexcom, Inc.Inventors: Colin Anthony Steele, Stephen D. Patek
-
Patent number: 12778461Abstract: A method of predicting future blood glucose concentrations of an individual patient includes: identifying an individualized linear black box model of glucose-insulin by estimating a plurality of impulse response functions each accounting for an input-output relation of a plurality of individualized patient data sets, the impulse response functions being functions in a Reproducing Kernel Hilbert Space (RKHS); and applying a linear predicting technique to the selected model using the identified impulse response functions to obtain a predicted blood glucose concentration of the individual patient at a future time.Type: GrantFiled: December 22, 2021Date of Patent: November 3, 2026Assignee: Dexcom, Inc.Inventors: Simone Del Favero, Andrea Facchinetti, Simone Faccioli, Gianluigi Pillonetto, Giovanni Sparacino
-
Patent number: 12774978Abstract: Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises a biointerface layer which interfaces with a biological fluid containing the analyte to be measured. The biointerface layer can comprises a biointerface polymer, wherein the biointerface polymer comprises polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The sensing membrane can also comprise an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The sensing membrane can also comprise a diffusion-resistance layer, which can comprise a base polymer having a lowest Tg of greater than ?50 C.Type: GrantFiled: December 23, 2021Date of Patent: October 27, 2026Assignee: DEXCOM, INC.Inventors: Shanger Wang, Robert J. Boock, Andrew Trinin Dennis, Ted Tang Lee, Jeff T. Suri, David Sze, Mark A. Tapsak, Huashi Zhang, Jiong Zou
-
Patent number: 12773134Abstract: Disclosed herein are systems and methods for a continuous analyte monitoring system for measuring a concentration of a first analyte and concentration of a second analyte in a host. One such system utilizes a working electrode and a reference electrode to measure glucose concentration and oxygen concentration in bodily fluid of a host. The system includes a sensor control circuit that applies a first bias condition to the sensor to measure a first signal generated by the sensor indicative of a concentration of the first analyte. The sensor control circuit also applies a second bias condition to the sensor to measure a second signal generated by the sensor indicative of a concentration of a second analyte at the host.Type: GrantFiled: March 17, 2023Date of Patent: October 27, 2026Assignee: Dexcom, Inc.Inventors: Daiting Rong, Xiong Peng, Nicholas Vincent Apollo, Jonathan M Hughes, Wenjie Lan, Chris W Dring, Shane Richard Parnell, Ryan Lee Knoy, Peter C Simpson, Joshua Ray Windmiller, Nai-Jen Chang, Jie Zhu, Matthew S. Brown, Eric Ruike Zhao
-
Patent number: 12773170Abstract: Data describing glucose measurements is received from a continuous glucose monitoring (CGM) system worn by a user and predicted glucose values during a future time period are generated for the user based on the data. A determination is made that at least one of the predicted glucose values satisfies a threshold value for an alert, which is associated with a prediction horizon that defines an amount of time prior to satisfaction of the threshold value for communicating the alert to the user. Output of the alert is caused responsive to determining that the at least one predicted glucose value satisfies the threshold value for the alert within the prediction horizon, relative to a current time. The prediction horizon is modified based on a user response to the alert. Output of a subsequent instance of the alert is caused based on the modified prediction horizon.Type: GrantFiled: September 1, 2021Date of Patent: October 27, 2026Assignee: Dexcom, Inc.Inventors: Lauren Hruby Jepson, Sarah Kate Pickus, Joost van der Linden
-
Publication number: 20260325019Abstract: Systems and methods for wireless communication of analyte information are disclosed. Example embodiments include an analyte sensor system. The analyte sensor system may include an analyte sensor to gather information related to a level of an analyte in a host. The analyte sensor system may include circuitry to transmit and receive wireless signals using a first antenna. The analyte sensor may be coupled to the circuitry before the analyte sensor system is transitioned into an operational state. The analyte sensor system may include a second antenna to receive an input signal from a source external to the analyte sensor system and to transmit a modified signal. The circuitry may use the first antenna to receive the modified signal The analyte sensor system may transition into the operational state in response to the modified signal received using the first antenna.Type: ApplicationFiled: July 2, 2026Publication date: October 22, 2026Applicant: Dexcom, Inc.Inventors: Patrick John CASTAGNA, David A. KELLER, Warren TERRY
-
Publication number: 20260332397Abstract: Techniques for performing application-layer security are disclosed. In certain embodiments, analyte data may be obtained from an analyte sensor operatively coupled to a sensor electronics module of an analyte sensor system. Thereafter, the analyte data may be encrypted, in an application layer of a protocol stack of the sensor electronics module using a session key established between the analyte sensor system and a display device. The encrypted analyte data may then be transmitted to a display device.Type: ApplicationFiled: July 2, 2026Publication date: October 22, 2026Applicant: Dexcom, Inc.Inventors: Jorge R. BARRERAS, Reinier SANCHEZ BAO, Aniel ALVAREZ
-
Publication number: 20260309670Abstract: Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The enzyme layer protects the enzyme and prevents it from leaching from the sensing membrane into a host or deactivating.Type: ApplicationFiled: January 21, 2026Publication date: October 8, 2026Applicant: DexCom, Inc.Inventors: Jiong Zou, Robert J. Boock, Andrew Trinin Dennis, Ted Tang Lee, Jeff T. Suri, David Sze, Mark A. Tapsak, Huashi Zhang, Shanger Wang
-
Patent number: 12749577Abstract: Techniques for enhancing sharing of a user's analyte data and techniques for enhancing social support provided to users for managing users' health are disclosed.Type: GrantFiled: December 19, 2023Date of Patent: September 29, 2026Assignee: Dexcom, Inc.Inventors: Carly Rose Olson, Afshan A. Kleinhanzl, Adam G. Noar, Harry Shaw Strothers, Andrew Merrill Terry, Michiko Araki Kelley, Afsaneh Sofia Sadri, Amit Premal Joshipura, Benjamin E. West, Apurv U. Kamath, Michele Leah Cambou, Alexander Michael Diener, Stacey Lynne Fischer, Douglas S. Kanter, Mark Derdzinski, Chad M. Patterson
-
Publication number: 20260288926Abstract: Measurements of biometric information of a user are obtained over time, such as blood glucose measurements. These biometric measurements are typically obtained by a wearable biometric information monitoring device being worn by the user. These biometric measurements are used by various different systems, such as a computing device of the user or a biometric information monitoring platform that receives biometric measurements from multiple different users. The biometric measurements are used for various security aspects, such as one or more of part of multi-factor authentication of the user, generating security keys (e.g., connection keys, encryption keys), identifying biometric measurements associated with different user identifiers but the same use, and protecting biometric measurements so as to be retrievable only by a recipient associated with an additional computing device, and so forth.Type: ApplicationFiled: May 28, 2026Publication date: September 24, 2026Applicant: Dexcom, Inc.Inventors: Thomas Hall, Andrew Attila Pal, Matthew Lawrence Johnson, Issa S. Salameh, Christopher Efigenio, Michael Tyler
-
Publication number: 20260272300Abstract: The present disclosure relates to systems and methods for activating a circuit of an implant device. Consistent with one implementation, an implant device is provided with a sensor including a working electrode (WE) and a counter electrode (CE). The sensor may be configured to generate a first current at the CE when the implant device is implanted in a body of a subject. A sensing circuit may also be provided that is electrically coupled to the WE of the sensor. The sensing circuit may be activated based on the first current and utilize the sensor to measure one or more parameters of an individual or other subject.Type: ApplicationFiled: May 11, 2026Publication date: September 17, 2026Applicants: Dexcom, Inc., Verily Life Sciences LLCInventors: Alireza DASTGHEIB, Johan VANDERHAEGEN
-
Patent number: 12733866Abstract: Techniques for generating a user interface view including sensor data representative of analyte levels of a host are disclosed. In certain embodiments, a technique includes accessing sensor data including a plurality of analyte readings of the host during a plurality of time periods, wherein each analyte reading is indicative of an analyte level of the host at a respective time. The technique further includes generating a first user interface (UI) view comprising one or more UI elements based on the plurality of analyte levels of the host, and, in response to receiving a user selection of a pregnancy mode, automatically modifying a parameter of at least one UI element included in the one or more UI elements to reflect a pregnancy-specific parameter. The technique further includes generating a second UI view based on the plurality of analyte levels of the host and the pregnancy-specific parameter.Type: GrantFiled: November 16, 2023Date of Patent: September 15, 2026Assignee: Dexcom, Inc.Inventors: Charles R. Stroyeck, Sonya Frangopoulos, Douglas S. Kanter, Afshan Kleinhanzl, Shelbi Lyn Howard, Joann Nhu, Maren Bean, Kazanna C. Hames, Lindsey Franklin
-
Patent number: 12733842Abstract: Systems and methods described provide dynamic and intelligent ways to change the required level of user interaction during use of a monitoring device. The systems and methods generally relate to real time switching between a first or initial mode of user interaction and a second or new mode of user interaction. In some cases, the switching will be automatic and transparent to the user, and in other cases user notification may occur. The mode switching generally affects the user's interaction with the device, and not just internal processing. The mode switching may relate to calibration modes, data transmission modes, control modes, or the like.Type: GrantFiled: March 3, 2016Date of Patent: September 15, 2026Assignee: Dexcom, Inc.Inventors: Naresh C. Bhavaraju, Michael A. Bloom, Leif N. Bowman, Alexandra Lynn Carlton, Katherine Yerre Koehler, Hari Hampapuram, Jonathan Hughes, Lauren Hruby Jepson, Apurv Ulas Kamath, Anna Leigh Davis, Peter C. Simpson, Stephen J. Vanslyke
-
Patent number: 12727793Abstract: Devices and methods for measuring a concentration of a target analyte in a biological fluid in vivo are provided herein. In some examples, a device includes an indwelling sensor and sensor electronics. The sensor may include a substrate; a first electrode disposed on the substrate; an ionophore disposed on the substrate to selectively transport the target ion to or within the first electrode; and a second electrode disposed on the substrate. The sensor electronics is configured to generate a signal corresponding to an electromotive force which is at least partially based on a potential difference that is generated between the first electrode and the second electrode responsive to the ionophore transporting the target ion to the first electrode.Type: GrantFiled: September 1, 2023Date of Patent: September 8, 2026Assignee: DEXCOM, INC.Inventors: Berta Esteban Fernandez de Avila, Devon M. Headen, Stacy Hunt DuVall, Jiong Zou, Shane Richard Parnell, Nicholas Vincent Apollo, Joshua Ray Windmiller
-
Patent number: 12717961Abstract: A method and system for generating synthetic data is provided. Longitudinal time series data are retrieved, and a neural network is trained to generate synthetic time series data that satisfies a privacy metric based on the longitudinal time series data. The longitudinal time series data are unlabeled and univariate.Type: GrantFiled: September 27, 2023Date of Patent: August 25, 2026Assignee: Dexcom, Inc.Inventor: Josephine Lamp
-
Patent number: 12702361Abstract: Systems and methods for providing sensitive and specific alarms indicative of glycemic condition are provided herein. In an embodiment, a method of processing sensor data by a continuous analyte sensor includes: evaluating sensor data using a first function to determine whether a real time glucose value meets a first threshold; evaluating sensor data using a second function to determine whether a predicted glucose value meets a second threshold; activating a hypoglycemic indicator if either the first threshold is met or if the second threshold is predicted to be met; and providing an output based on the activated hypoglycemic indicator.Type: GrantFiled: March 7, 2023Date of Patent: August 11, 2026Assignee: Dexcom, Inc.Inventors: Hari Hampapuram, Anna Leigh Davis, Naresh C. Bhavaraju, Apurv Ullas Kamath, Claudio Cobelli, Giovanni Sparacino, Andrea Facchinetti, Chiara Zecchin
-
Publication number: 20260224136Abstract: An example continuous glucose monitor includes a printed circuit board (“PCB”) having first and second outer layers and an inner layer; a semiconductor package having a plurality of pins coupled to the first outer layer of the PCB; an electrical contact formed on the second outer layer of the PCB; a trace having a first portion disposed on the first outer layer, a second portion disposed on the inner layer, and a third portion disposed on the second outer layer, the trace having a first end coupled to a first pin of the plurality of pins and a second end coupled to the electrical contact; and an encapsulant disposed around a perimeter of the semiconductor package, the encapsulant covering the plurality of pins, the first portion of the sensor trace, the third portion of the sensor trace, wherein an upper surface of the semiconductor package remains exposed.Type: ApplicationFiled: March 27, 2026Publication date: August 6, 2026Applicants: DexCom, Inc., Verily Life Sciences LLCInventors: Mandy Philippine, Scott Matula, Johan Vanderhaegen, Louis Jung, Nivi Arumugam
-
Patent number: D1152028Type: GrantFiled: July 1, 2024Date of Patent: October 6, 2026Assignee: Dexcom, Inc.Inventors: Todd Andrew Newhouse, Ryan E. Schoonmaker
-
Patent number: D1152029Type: GrantFiled: July 1, 2024Date of Patent: October 6, 2026Assignee: Dexcom, Inc.Inventors: Todd Andrew Newhouse, Ryan Schoonmaker